Analgesics
Antiandrogens
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
Top
Results
Abstract
All thermotherapy studies
Meta analysis
 
Feedback
Home
next
study
previous
study
c19early.org COVID-19 treatment researchThermotherapyThermotherapy (more..)
Melatonin Meta
Metformin Meta
Azvudine Meta
Bromhexine Meta Molnupiravir Meta
Budesonide Meta
Colchicine Meta
Conv. Plasma Meta Nigella Sativa Meta
Curcumin Meta Nitazoxanide Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis    Recent:   
0 0.5 1 1.5 2+ Mortality, day 28 43% Improvement Relative Risk Mortality, day 14 43% Ventilation 21% Progression 17% Thermotherapy  TherMoCoV  LATE TREATMENT  RCT Is late treatment with thermotherapy beneficial for COVID-19? RCT 105 patients in Mexico (August 2020 - August 2021) Lower mortality with thermotherapy (not stat. sig., p=0.28) c19early.org Mancilla-Galindo et al., Frontiers in .., Dec 2023 Favors thermotherapy Favors control

Regional moderate hyperthermia for mild-to-moderate COVID-19 (TherMoCoV study): a randomized controlled trial

Mancilla-Galindo et al., Frontiers in Medicine, doi:10.3389/fmed.2023.1256197, TherMoCoV, NCT04363541
Dec 2023  
  Post
  Facebook
Share
  Source   PDF   All   Meta
42nd treatment shown to reduce risk in December 2023
 
*, now known with p = 0.026 from 4 studies.
Lower risk for recovery.
No treatment is 100% effective. Protocols combine complementary and synergistic treatments. * >10% efficacy in meta analysis with ≥3 clinical studies.
4,000+ studies for 60+ treatments. c19early.org
RCT 105 hospitalized patients with mild-to-moderate COVID-19, evaluating the efficacy and safety of local thermotherapy (heating pads applied to the chest for 90 minutes twice daily for 5 days) to prevent disease progression, compared to standard care alone. The thermotherapy was well-tolerated with no significant adverse events.
Reduction in NEWS-2 score was significantly faster with treatment. There was lower progression and mortality with treatment, without statistical significance. The study was underpowered due to early termination.
The temperature used may be too low. Lung temperature is expected to be lower than the external skin surface temperature measured on the thorax, due to heat diffusion and dissipation that occurs in transferring thermal energy across the tissue layers of skin, adipose, muscle, connective tissue and bone between the heating pad and the lung.
The treatment group had greater severity at baseline, NEWS-2 7 vs. 5, and PH-COVID-19 high-risk 7.5% vs. 0%.
Mortality numbers do not match - Figure 3 shows 10 control deaths at 28 days, while Table 3 shows 8. Percentages reported in Table 3 do not match the counts.
ICU numbers do not match the other data, for example in the control group 6 patients required invasive mechanical ventilation and 10 patients died, but only 3 patients were admitted to the ICU.
risk of death, 43.3% lower, RR 0.57, p = 0.28, treatment 6 of 54 (11.1%), control 10 of 51 (19.6%), NNT 12, day 28.
risk of death, 43.3% lower, RR 0.57, p = 0.48, treatment 3 of 54 (5.6%), control 5 of 51 (9.8%), NNT 24, day 14.
risk of mechanical ventilation, 21.3% lower, RR 0.79, p = 0.76, treatment 5 of 54 (9.3%), control 6 of 51 (11.8%), NNT 40.
risk of progression, 17.4% lower, RR 0.83, p = 0.67, treatment 14 of 54 (25.9%), control 16 of 51 (31.4%), NNT 18.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Mancilla-Galindo et al., 22 Dec 2023, Randomized Controlled Trial, Mexico, peer-reviewed, median age 53.0, 15 authors, study period 27 August, 2020 - 23 August, 2021, heating pad, trial NCT04363541 (history) (TherMoCoV). Contact: ngalindosevilla@hotmail.com.
This PaperThermotherapyAll
Regional moderate hyperthermia for mild-to-moderate COVID-19 (TherMoCoV study): a randomized controlled trial
Javier Mancilla-Galindo, Ashuin Kammar-García, María De Lourdes Mendoza-Gertrudis, Javier Michael García Acosta, Yanira Saralee Nava Serrano, Oscar Santiago, Miriam Berenice Torres Vásquez, Daniela Martínez Martínez, Liliana Aline Fernández-Urrutia, Julio César Robledo Pascual, Iván Daniel Narváez Morales, Andrea Aida Velasco-Medina, Javier Mancilla-Ramírez, Ricardo Figueroa-Damián, Norma Galindo-Sevilla
Frontiers in Medicine, doi:10.3389/fmed.2023.1256197
Background: To prevent COVID-19 progression, low-cost alternatives that are available to all patients are needed. Diverse forms of thermotherapy have been proposed to prevent progression to severe/critical COVID-19. Objective: The aim of this study is to evaluate the efficacy and safety of local thermotherapy to prevent disease progression in hospitalized adult patients with mild-to-moderate COVID-19. Methods: A multicenter, open-label, parallel-group, randomized, adaptive trial is used to evaluate the efficacy and safety of local thermotherapy to prevent disease progression in hospitalized adult patients with mild-tomoderate COVID-19. Eligible hospitalized adult patients with symptoms of COVID-19 with ≤5 days from symptom onset, meeting criteria for mild or moderate COVID-19, were randomly assigned to the intervention consisting of local thermotherapy via an electric heat pad in the thorax (target temperature range 39.5-42°C) continuously for 90 min, twice daily, for 5 days, or standard care. The main outcome was the proportion of patients who progressed to severe-to-critical COVID-19 or death. Patients were randomized in a 1:1 ratio through a centralized computer-generated sequence of minimization with a random component of 20%. Participants and medical staff were not blinded to the intervention.
Ethics statement The studies involving humans were approved by Dirección General de Calidad y Educación en Salud (CEI-DGCES/2020:03.1) and Instituto Nacional de Perinatología (2020-1- 19) . The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study. Author contributions Conflict of interest The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. Publisher's note All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher. Supplementary material The Supplementary material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fmed.2023.1256197/ full#supplementary-material
References
Asiimwe, Pushpakom, Turner, Kolamunnage-Dona, Jorgensen et al., Cardiovascular drugs and COVID-19 clinical outcomes: a systematic review and meta-analysis of randomized controlled trials, Br J Clin Pharmacol, doi:10.1111/bcp.15331
Basto-Abreu, Carnalla, Torres-Ibarra, Sanchez-Pájaro, Romero-Martínez et al., SARS-CoV-2 seroprevalence and vaccine coverage from august to November 2021: a nationally representative survey in Mexico, J Med Virol, doi:10.1002/jmv.29038
Bautista-Reyes, Werner-Sunderland, Gama, Duran, Medina et al., Health-care policies during the COVID-19 pandemic in Mexico: a continuous case of heterogeneous, reactive, and unequal response, Health Policy Open, doi:10.1016/j.hpopen.2023.100100
Bierer, Meloney, Ahmed, White, Advancing the inclusion of underrepresented women in clinical research, Cell Rep Med, doi:10.1016/j.xcrm.2022.100553
Bonfanti, Mohr, Willms, Bedimo, Gundert et al., Core warming of coronavirus disease 2019 patients undergoing mechanical ventilation: a pilot study, Ther Hypothermia Temp Manag, doi:10.1089/ther.2023.0030
Cohen, Turning up the heat on COVID-19: heat as a therapeutic intervention, F1000Research, doi:10.12688/f1000research.23299.1
Core, R: A language and environment for statistical computing
Dayim, Consort, Create consort diagram
Flahault, Calmy, Costagliola, Drapkina, Eckerle et al., No time for complacency on COVID-19 in Europe, Lancet, doi:10.1016/S0140-6736(23)01012-7
Gandhi, Lynch, Del Rio, Mild or moderate Covid-19, N Engl J Med, doi:10.1056/NEJMcp2009249
Gazel, Yılmaz, Are infectious diseases and microbiology new fields for thermal therapy research?, Int J Hyperth, doi:10.1080/02656736.2018.1440015
Guillaumes, Callaghan, Versión en español del software gratuito OxMaR para minimización y aleatorización de estudios clínicos, Gac Sanit, doi:10.1016/j.gaceta.2018.07.013
Guyatt, Briel, Glasziou, Bassler, Montori, Problems of stopping trials early, BMJ, doi:10.1136/bmj.e3863
Hampton, Eccleston-Turner, Rourke, Switzer, Equity in the pandemic treaty: access and benefit-sharing as a policy device or a rhetorical device?, J Law Med Ethics, doi:10.1017/jme.2023.59
Han, Ma, Li, Liu, Zhao et al., Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors, Emerg Microbes Infect, doi:10.1080/22221751.2020.1770129
Huang, Cheng, Lin, Zhu, Chen, Individualized prediction nomograms for disease progression in mild COVID-19, J Med Virol, doi:10.1002/jmv.25969
Huang, Hernandez, Tang, Dickson, Berenbrok et al., Association between distance to community health care facilities and COVID-19-related mortality across U.S. counties in the COVID-19-vaccine era, BMC Res Notes, doi:10.1186/s13104-023-06366-3
Huang, Li, Shah, Nasb, Ali et al., Efficacy and safety of ultrashort wave diathermy on COVID-19 pneumonia: a pioneering study, Front Med, doi:10.3389/fmed.2023.1149250
Lamontagne, Agarwal, Rochwerg, Siemieniuk, Agoritsas et al., A living WHO guideline on drugs for covid-19, BMJ, doi:10.1136/bmj.m3379
Liikkanen, Laukkanen, Sauna bathing frequency in Finland and the impact of COVID-19, Complement Ther Med, doi:10.1016/j.ctim.2020.102594
Liu, Li, Liu, Liang, Wang et al., Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients, EBioMedicine, doi:10.1016/j.ebiom.2020.102763
Mancilla-Galindo, Galindo-Sevilla, Exploring the rationale for thermotherapy in COVID-19, Int J Hyperth, doi:10.1080/02656736.2021.1883127
Mancilla-Galindo, Vera-Zertuche, Navarro-Cruz, Segura-Badilla, Velázquez et al., Development and validation of the patient history COVID-19 (PH-Covid19) scoring system: a multivariable prediction model of death in Mexican patients with COVID-19, Epidemiol Infect, doi:10.1017/S0950268820002903
Marshall, Murthy, Diaz, Adhikari, Angus et al., A minimal common outcome measure set for COVID-19 clinical research, Lancet Infect Dis, doi:10.1016/S1473-3099(20)30483-7
Masaud, Szasz, Szasz, Ejaz, Anwar et al., A potential bioelectromagnetic method to slow down the progression and prevent the development of ultimate pulmonary fibrosis by COVID-19, Front Immunol, doi:10.3389/fimmu.2020.556335
O'callaghan, OxMaR: open source free software for online minimization and randomization for clinical trials, PLoS ONE, doi:10.1371/journal.pone.0110761
Perez-Padilla, Bouscoulet, Muiño, Marquez, Lopez et al., Prevalance of oxygen desaturation and use of oxygen at home in adults at sea level and at moderate altitude, Eur Respir J, doi:10.1183/09031936.06.00075005
Plata, The black market for covid-19 antiviral drugs, BMJ, doi:10.1136/bmj.o1282
Ramirez, Sanchez, Pirskanen, Hydrothermotherapy in prevention and treatment of mild to moderate cases of COVID-19, Med Hypotheses, doi:10.1016/j.mehy.2020.110363
Ren, Wang, Han, Statins in hospitalized COVID-19 patients: a systematic review and meta-analysis of randomized controlled trials, J Med Virol, doi:10.1002/jmv.28823
Rivera Pérez, Suárez Nadal, Kurschansky, Las, De et al., Saturación de oxígeno en adultos mayores de la Ciudad de México, An Méd
Smith, Latin America roundup: COFEPRIS ends emergency fast tracking for new COVID vaccines, Regulatory Focus
Sánchez-De Prada, Galindo, Fierro, Martínez-García, De Quintana et al., Time evolution of cytokine profiles associated with mortality in COVID-19 hospitalized patients, Front Immunol, doi:10.3389/fimmu.2022.946730
Tian, Wang, Xi, Sun, He et al., Efficacy and safety of short-wave diathermy treatment for moderate COVID-19 patients: a prospective, double-blind, randomized controlled clinical study, Eur J Phys Rehabil Med, doi:10.23736/S1973-9087.21.06892-1
Vargas-Domínguez, Gochicoa-Rangel, Velázquez-Uncal, Mejía-Alfaro, Vázquez-García et al., Pruebas de función respiratoria, ¿cuál y a quién?, Neumol Cir Torax
Vera-Zertuche, Mancilla-Galindo, Tlalpa-Prisco, Aguilar-Alonso, Aguirre-García et al., Obesity is a strong risk factor for short-term mortality and adverse outcomes in Mexican patients with COVID-19: a national observational study, Epidemiol Infect, doi:10.1017/S0950268821001023
Viena, R Foundation for Statistical Computing
Wang, Fan, Horby, Hayden, Li et al., Comparative outcomes of adults hospitalized with seasonal influenza a or B virus infection: application of the 7-category ordinal scale, Open forum. Infect Dis, doi:10.1093/ofid/ofz053
Wu, Mcgoogan, Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China, JAMA, doi:10.1001/jama.2020.2648
Zhang, Wu, Pan, Shen, D-dimer levels and characteristics of lymphocyte subsets, cytokine profiles in peripheral blood of patients with severe COVID-19: a systematic review and meta-analysis, Front Med, doi:10.3389/fmed.2022.988666
Late treatment
is less effective
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit